I am disgusted with the way so many stockholders have
I am disgusted with the way so many stockholders have trashed Leo and Dr M regarding the new acquisition and the handling of the Prurisol trial. For the last 10 months or so all I heard was the singing of their praises, now I find out we have about 20 CEO caliber people on the CTIX boards that could really show Leo how to run a company. What is most appalling is that many have not had the common courtesy to allow Leo and Dr M to explain their actions and provide some background info as to what is progressing with the company as to these changes without a 20 minute limit. The lack of respect would set my teeth on edge if I was them.
I hope Leo and Dr M are better people than me for when somebody questions my attention to duty and basically my honor, I never forget and I never forgive. I would probably, going forward, give out a lot of "no comments" and issue information only as required by SEC rules. They really don't need us, we obviously don't appreciate them, so why spend a lot of time communicating. Dr M hobnobs with the greatest minds in American Medicine, yet we have many telling him how his Prurisol should be shepherded thru trials. Leo is a financial expert, yet he obviously went on a reckless spending spree that has now put the company in financial jeopardy according to many. This even after he made a joke at the presentation about no reverse split and continual comments saying no financial worries and he was bursting at the seams by all who saw him in person regarding what a coup this acquisition was for CTIX. A tremendous upgrade for Kard facilities, a new molecule development program of some type that could be remarkable, robust new pipeline of products, and all acquired for pennies on the dollar. What the hell could that idiot have been thinking to make a deal like that?
Seriously?
I see a few months of quiet time and I think I will back off the IHUB board due to the constant wailing that will be going on there as the stock price rises and falls.
I will make a prediction that within a few months some dramatic FURTHER good word will be given and those trashing mgt now will once again be singing their praises, acting as though nothing negative ever occurred, but I believe in the saying "a thing of beauty, once broken, can never be regained". Such it is with the relationship between mgt and many who claimed to be their supporters.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Pioneering Technology in Leave Management AbsenceSoft is rolling out a tool that's about to shake up the HR world in a big way. MyAbsence, powered by AbsenceSoftAI, seems ready to cut down on the common confusions that send HR folks spinning around like they're in a two-step dance competition, juggling leave requests and compliance checks. It's all about getting the...
Continue Reading
Systemair Breaks New Ground Hold onto your hats, because Systemair just sealed a deal that's going to make waves. Their recent accomplishment isn't just some humdrum business tedium—it's an intriguing step forward in the HVAC world. Systemair snagged their very first order for air handling units featuring an integrated heat pump and natural refrigerant. You've got to...
Continue Reading
IT Transformations: A Tough Nut to Crack Transforming IT systems isn't just about plugging in new tech. It's a beast of a task, fraught with pitfalls and peopled with ambitious project managers hoping to dodge them. Natuvion and PricewaterhouseCoopers (PwC) have put together a book that could be the guide folks need when wading into these complex waters. The 'Why' of...
Continue Reading
A Refreshing Jolt for Harbour BioMed's Growth Journey Harbour BioMed just threw down a new card by bringing in Ms. Vivian Feng as the Senior Vice President, Head of External Collaboration. There's a real sense of drive coming from this decision. When a biopharma outfit asserts its intent to ramp up growth, and they hang the hat on someone like Vivian, you better believe...
Continue Reading
Breaking The Mold Of Traditional Medicine MY DR NOW isn't here to play by the age-old rules. They're slinging open the doors to their newest family medicine clinics and kicking the old Monday-to-Friday scheduling straight to the curb. Every single day of the week, from 8 a.m. to 8 p.m., patients in Sunnyvale and Tucson are getting a dose of healthcare that's all about...
Continue Reading
Firing Up the Holiday Spirit with Cincoro Well, isn't this a timely toast to class? As if the tequila scene wasn't already brimming with options, Cincoro's decided to paint the town gold with a rare addition to its lineup. For those of you who treat your liquor collection like a stockpile of fine art, here's something that'll turn heads this holiday season—the Añejo...
Continue Reading
Small Spaces, Big Holiday Spirit Not everyone’s got the sprawling front yard of a mansion to decorate, but that doesn’t mean you have to miss out on holiday cheer. Gemmy’s latest pint-sized holiday inflatables hit the market this season, aiming straight for those of us with cozy porches and snug apartments. These little guys might measure only 3 to 5 feet tall, but...
Continue Reading
Eyeing the Road Ahead: Vital Market Growth Insights We've got ourselves a sector on the move. The ophthalmic equipment market, pegged at USD 21.2 billion in 2026, is set to climb up to a whopping USD 30.5 billion by 2031. Knowing that it’s growing at a steady clip of 7.5% CAGR over these years, there’s more than just a glimmer of opportunity for those savvy enough to...
Continue Reading
Tech and Football: An Unlikely Alliance Alright, so here's a story that might perk your ears up—RingConn, a relative newcomer in the health tech world, has chosen to stake its future on a bet with Borussia Dortmund's women's football team. This isn't just your average brand-sponsorship slap-on-the-shirt deal; we're looking at a potential game-changer here, folks. Who...
Continue Reading
Bluevua Sweeps the 2026 BASA Awards Stacking accolades like old trading wins, Bluevua just clinched not one, not two, but three 2026 Best of America Small Business Awards (BASA Awards®). If that's not a feather in their cap, I don't know what is. For the uninitiated, these BASA nods are no small potatoes—they're like the Oscars for small businesses. Bluevua, known for...
Continue Reading
Top 5 Most Recently Viewed Articles
Evaluating the P/E Ratio of Capital Southwest Currently, Capital Southwest Inc. (NASDAQ: CSWC) shares are trading at $21.52, reflecting a modest increase of 0.09%. Over the past month, the stock has seen a rise of 2.82%, while the yearly growth stands at 1.65%. Such performance tends to encourage long-term investors, but it also prompts others to scrutinize the...
Continue Reading
Roche’s Breakthrough with Lunsumio Roche is making significant strides in the treatment of follicular lymphoma with its innovative subcutaneous formulation of Lunsumio, a bispecific antibody designed to engage T-cells in battling this common form of non-Hodgkin lymphoma. Following a favorable recommendation from the European Medicines Agency’s Committee for Medicinal...
Continue Reading
Ayush Mittal Joins Trianz as Global Head of DT Services Trianz, an industry leader in digital transformation software and services, has recently announced the appointment of Ayush Mittal as its Senior Vice President and Global Head of Digital Transformation (DT) Services. Extensive Industry Experience With almost 30 years of rich experience in IT Infrastructure and Cloud...
Continue Reading
Introducing Quick Move-In Homes by Toll Brothers Recently, Toll Brothers, Inc. has unveiled a unique opportunity for homebuyers looking for luxurious living in a serene environment. Located in a beautiful setting, their Northfield community is designed to provide families with quick access to quality living. With a selection of move-in ready and quick move-in homes,...
Continue Reading
Nyxoah SA rocked the boat back in September 2024 when it revealed a transparency notification that set tongues wagging on the trading floor. The culprit? None other than BlackRock Advisors, LLC, which tumbled below that all-important 3% ownership threshold. If you think that's just numbers, think again; this shift speaks volumes about market dynamics and investor...
Continue Reading